Videos
Round 3: Frontline Therapy Across Age and Fitness Levels
10/28/2026
In the final round, panelists consider frontline treatment selection for an older, functionally independent patient, weighing toxicity profiles, administration approaches, supportive care, and dose modifications against treatment goals and quality of life.
To see arguments related to frontline therapy for the newly diagnosed patient, see Round 1.
To see arguments related to frontline therapy for patients with CNS disease and other high-risk features, see Round 2.
Transcript coming soon!
©️ 2026 HMP Global. All Rights Reserved.
This is a non-CME activity. The views and opinions expressed by the presenter(s) do not necessarily reflect the views and opinions of the Oncology Learning Network, HMP Global, or its employees and affiliates.
